Gastric antral vascular ectasia unmasked by alprostadil for digital ulceration in scleroderma.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 21459962)

Published in J Rheumatol on April 01, 2011

Authors

Mohammed A Omair, Sindhu R Johnson

Articles by these authors

2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum (2013) 5.99

2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis (2013) 3.11

A new toolkit for conducting clinical trials in rare disorders. J Popul Ther Clin Pharmacol (2014) 1.47

Factors that prognosticate mortality in idiopathic pulmonary arterial hypertension: a systematic review of the literature. Respir Med (2010) 1.16

Office capillaroscopy in systemic sclerosis. Clin Rheumatol (2006) 1.11

Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exercise. Arthritis Care Res (Hoboken) (2012) 1.06

Biologic therapy for systemic sclerosis: a systematic review. J Rheumatol (2010) 0.93

Magnetic resonance imaging of the hand in systemic sclerosis. J Rheumatol (2009) 0.88

Low bone density in systemic sclerosis. A systematic review. J Rheumatol (2013) 0.85

Ethnic influence on disease manifestations and autoantibodies in Chinese-descent patients with systemic sclerosis. J Rheumatol (2009) 0.84

Clinical evidence, practice guidelines, and β-blocker utilization before major noncardiac surgery. Circ Cardiovasc Qual Outcomes (2012) 0.81

A review of the sapporo and revised Sapporo criteria for the classification of antiphospholipid syndrome. Where do the revised sapporo criteria add value? J Rheumatol (2007) 0.80

Alternative designs for clinical trials in rare diseases. Am J Med Genet C Semin Med Genet (2016) 0.78

Survival after lung transplantation in systemic sclerosis. A systematic review. Respir Med (2013) 0.78

Long-term safety and effectiveness of tumour necrosis factor inhibitors in systemic sclerosis patients with inflammatory arthritis. Clin Exp Rheumatol (2012) 0.78

Classification in systemic sclerosis. J Rheumatol (2006) 0.77

Survival in rheumatoid arthritis-associated pulmonary arterial hypertension compared with idiopathic pulmonary arterial hypertension. Respirology (2015) 0.77

Development, sensibility, and reliability of the Toronto Axial Spondyloarthritis Questionnaire in inflammatory bowel disease. J Rheumatol (2013) 0.76

Surveys, samplings and botched US presidential election predictions. Eur J Anaesthesiol (2012) 0.76

Inflammatory arthritis, sacroiliitis, and morphea: evidence of a systemic inflammatory disease. Case Rep Rheumatol (2013) 0.75

Effectiveness of phosphodiesterase-5 inhibitor therapy for portopulmonary hypertension. Can Respir J (2014) 0.75

Herod the Great and polyarteritis nodosa. Arch Intern Med (2004) 0.75

Bayesian inference: statistical gimmick or added value? J Rheumatol (2011) 0.75

Disease modification and other trials in systemic sclerosis have come a long way, but have to go further. Arthritis Care Res (Hoboken) (2012) 0.75

Erectile dysfunction and scleroderma. J Rheumatol (2004) 0.75

ANCA-associated vasculitis in systemic sclerosis report of 3 cases. Rheumatol Int (2012) 0.75

How Much Better Is Good Enough?: Patient-reported Outcomes, Minimal Clinically Important Differences, and Patient Acceptable Symptom States in Perioperative Research. Anesthesiology (2016) 0.75

Development of adenocarcinoma of the lung in a transplanted lung of a scleroderma patient. Clin Exp Rheumatol (2012) 0.75